Pages that link to "Q28575781"

The following pages link to Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways (Q28575781):

Displaying 44 items.

• Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins (Q24329069) (← links)
• Non-ionotropic signaling by the NMDA receptor: controversy and opportunity (Q26745925) (← links)
• Emerging Link between Alzheimer's Disease and Homeostatic Synaptic Plasticity (Q26750576) (← links)
• Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease (Q26765782) (← links)
• Dopamine-induced plasticity, phospholipase D (PLD) activity and cocaine-cue behavior depend on PLD-linked metabotropic glutamate receptors in amygdala (Q27317658) (← links)
• Homer scaffold protein 1 (Q28561720) (← links)
• Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex (Q33813237) (← links)
• Molecular mechanisms of neurodegeneration in Alzheimer's disease (Q33871297) (← links)
• CDK5 is essential for soluble amyloid β-induced degradation of GKAP and remodeling of the synaptic actin cytoskeleton (Q33988231) (← links)
• Successful cognitive aging in rats: a role for mGluR5 glutamate receptors, homer 1 proteins and downstream signaling pathways (Q34124967) (← links)
• Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation (Q34553583) (← links)
• Molecular reorganization of endocannabinoid signalling in Alzheimer's disease (Q34754667) (← links)
• Soluble oligomers of amyloid-β peptide disrupt membrane trafficking of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor contributing to early synapse dysfunction. (Q35144851) (← links)
• Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody (Q35151492) (← links)
• Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold (Q35290019) (← links)
• Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology (Q36485712) (← links)
• Metabotropic NMDA receptor function is required for β-amyloid-induced synaptic depression. (Q36673182) (← links)
• Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease (Q36824513) (← links)
• APP Causes Hyperexcitability in Fragile X Mice (Q37504141) (← links)
• Structure of metabotropic glutamate receptor C-terminal domains in contact with interacting proteins (Q38005681) (← links)
• Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins. (Q38024032) (← links)
• What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders (Q38038399) (← links)
• Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases (Q38044699) (← links)
• Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain (Q38054714) (← links)
• The emerging role of SHANK genes in neuropsychiatric disorders (Q38152438) (← links)
• Dendritic spines: the locus of structural and functional plasticity (Q38175135) (← links)
• The Potential Role of Insulin on the Shank-Postsynaptic Platform in Neurodegenerative Diseases Involving Cognition (Q38178230) (← links)
• Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions (Q38770806) (← links)
• Amyloid-β Oligomers Interact with Neurexin and Diminish Neurexin-mediated Excitatory Presynaptic Organization (Q38955415) (← links)
• Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease (Q38957610) (← links)
• Protective effect of Homer 1a on tumor necrosis factor-α with cycloheximide-induced apoptosis is mediated by mitogen-activated protein kinase pathways (Q39337903) (← links)
• Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer's and neurodegenerative diseases (Q39418685) (← links)
• NMDA receptors and BAX are essential for Aβ impairment of LTP. (Q40408420) (← links)
• Developing BACE-1 inhibitors for FXS. (Q41073215) (← links)
• Role of BACE1 in Alzheimer's synaptic function. (Q41555225) (← links)
• Imaging for metabotropic glutamate receptor subtype 1 in rat and monkey brains using PET with [18F]FITM. (Q44093362) (← links)
• Protective effects of Bushen Tiansui decoction on hippocampal synapses in a rat model of Alzheimer's disease (Q47101866) (← links)
• Differential Regulation of N-Methyl-D-Aspartate Receptor Subunits is an Early Event in the Actions of Soluble Amyloid-β(1-40) Oligomers on Hippocampal Neurons (Q48933239) (← links)
• nArgBP2-SAPAP-SHANK, the core postsynaptic triad associated with psychiatric disorders. (Q52328704) (← links)
• Biochemical and immunological aspects of protein aggregation in neurodegenerative diseases (Q57405353) (← links)
• Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease (Q64053941) (← links)
• Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer’s disease (Q64109078) (← links)
• Nutrient limitation affects presynaptic structures through dissociable Bassoon autophagic degradation and impaired vesicle release (Q89417933) (← links)
• The epilepsy and intellectual disability-associated protein TBC1D24 regulates the maintenance of excitatory synapses and animal behaviors (Q89467107) (← links)